Natural killer (NK) cell biology are cells that specifically detect and eradicate cancer cells. In his presentation, Professor Huntington will navigate virtual participants through how NK cells offer a safe cancer immunotherapy target and discuss therapeutic strategies to harness NK cell activity that are being developed at a rapid rate.
Professor Nick Huntington
Professor Huntington is the head of the Cancer Immunotherapy Laboratory at the Biomedicine Discovery Institute at Monash University. He is an international leader on natural killer (NK) cell biology with notable contributions to:
- regulatory mechanisms of IL-15 signalling in NK cells
- identification of human and murine NK cell differentiation pathways
- novel xenograft models to study human hematopoiesis and;
- identification of multiple checkpoint in NK cell activation and tumour immunity
Professor Huntington leads a research program aimed at deciphering the regulatory networks that control NK cell immunity and a drug discovery program using cutting-edge in vivo screens for novel checkpoints in NK cell activation for targeting in cancer immunotherapy. He is President of the Melbourne Immunotherapy Network (MIN) and is a co-founder and Chief Scientific Officer of oNKo-Innate Pty Ltd.
Monday 8 February